Agent Capital, LLC

About

Agent Capital | Healthcare Venture Capital Firm | Biotechnology About Portfolio Strategy News Contact About Portfolio Strategy News Contact TODAY'S INVESTMENT. TOMORROW'S BREAKTHROUGH. Addressing unmet patient needs through groundbreaking innovations --> INVESTMENTS THAT MATTER Agent Capital is a healthcare venture capital firm focused on investing in novel, differentiated therapeutics and treatments that address unmet patient needs. Across all stages of development, we align ourselves with scientists, entrepreneurs and other investors to develop the next generation of healthcare innovations that will have a positive impact on patients’ lives. Learn More OUR PROVEN STRATEGY At Agent Capital, we proactively guide biotech companies to milestones and exits. With a balanced investment approach and a deep understanding of biopharma’s pipeline pressures, we are committed to making investments that move healthcare forward – no matter the stage or investment type. TYPICALLY, OUR KEY INVESTMENT AREAS OF FOCUS INCLUDE: Rare Diseases Oncology Neurology Immunology Learn More Featured Portfolio Company Dice Therapeutics Freenome Metagenomi Pliant Therapeutics ViTToria Biotherapeutics Dragonfly Therapeutics Carisma Therapeutics Skyhawk Therapeutics Flare Therapeutics ImCheck Therapeutics Orchard Therapeutics Entrada Therapeutics Zenas Biopharma Star Therapeutics Pyxis Oncology Precision Biosciences Palvella Therapeutics View Full Portfolio Featured News Press Release | June 8, 2026 Incyte

Key Contact

Geographic Focus